Manufacturing and Production

Showing 15 posts of 5857 posts found.

michael-jewell

Funding overview for the pharmaceutical industry and outlook for 2020

March 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus

The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …
pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

February 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes

The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
nice_new_london_office_internal_3_web

NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma

February 26, 2020 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche

It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

February 25, 2020 Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma

A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
peoples_assembly_20150620

Austerity policies blamed as English life expectancy stalls for first time in a century

February 25, 2020 Manufacturing and Production England, NHS England, UCL, austerity, life expectancy

A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …

FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol

February 25, 2020 Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma

Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …
homoopathie-globuli-naturopathy-naturopaths-homeopathy-beads-royalty-free-thumbnail

World’s second largest API company to be created by Sanofi

February 25, 2020 Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
26682732344_ae569bf0e3_b

US domestic supply of 150 drugs under threat from coronavirus outbreak

February 25, 2020 Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …
160x100

2020 Veeva Unified Clinical Operations Survey

February 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
janssen_latest_logo_on_sign_closer

Janssen shows off Phase 3b interim data for Stelara in Crohn’s disease

February 18, 2020 Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma

Janssen has revealed new interim Phase 3b data from a study investigating the efficacy of Stelara (ustekinumab) in the treatment …
160324-f-hc995-002

Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children

February 18, 2020 Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland

The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …

Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration

February 18, 2020 Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma

The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
merck-keytruda-pembrolizumab-melanoma

NICE gives initial ‘no’ to NHS England for kidney cancer drug

February 18, 2020 Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda

The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …
The Gateway to Local Adoption Series

Latest content